Shine-On BioMedical Co.,Ltd. (TPEX:6926)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
63.20
-0.80 (-1.25%)
Jun 18, 2026, 2:23 PM CST
Market Cap3.15B -4.5%
Revenue (ttm)30.00M
Net Income-110.29M
EPS-2.21
Shares Out 49.80M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume7,110
Open64.00
Previous Close64.00
Day's Range61.10 - 64.10
52-Week Range60.70 - 81.60
Beta-0.14
Analystsn/a
Price Targetn/a
Earnings DateAug 10, 2026

About Shine-On BioMedical

Shine-On BioMedical Co.,Ltd. research, develops, and manufactures anti-cancer related drug products. It also develops antibody anticancer drugs, such as exosome anti-cancer drugs, that includes SOB101 and SOB102; SOB201 for engineered multi-target exosomes; SOA101, a dual immune checkpoint T cell adapter antibody; and SOA201, a trispecific adapter immune cell antibody. Shine-On BioMedical Co.,Ltd. was founded in 2011 and is based in Taichung, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2011
Employees 22
Stock Exchange Taipei Exchange
Ticker Symbol 6926
Full Company Profile

Financial Performance

Financial Statements